OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Dermatology is 42. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
Living with vulval lichen sclerosus: a qualitative interview study	269
Integrating artificial intelligence into skin cancer pathways: the opportunities and obstacles	218
352 Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: a post-hoc analysis of the JADE REGIMEN phase 3 trial	176
335 Improvement in sleep quality, anxiety and depression in adults with moderate-to-severe atopic dermatitis with dupilumab treatment	89
Greater understanding about differences in the long-term course of eczema and their risk factors in children	81
Epidemiology, comorbidities and mortality of pyoderma gangrenosum: new insights	74
520 - Evaluating the expression of OX40 and OX40 ligand in lesional skin versus non-lesional skin in volunteers with atopic dermatitis and in healthy control skin	72
561 - Dupilumab treatment reduces signs in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial	71
Relationship between atopic dermatitis, depression and anxiety: a two‐sample Mendelian randomization study	70
Higher proportion of cellulitis in severe lymphoedema	68
COVID-19 vaccines and skin manifestations	67
677 - Establishing a patient-centered definition of atopic dermatitis flare: insights from a modified eDelphi study	66
691 - Understanding patient and physician preferences when choosing between biologic and oral systemic treatment options for moderate-to-severe atopic dermatitis: a discrete choice experiment	66
643 - Effectiveness and safety of upadacitinib in adolescent and adult patients with atopic dermatitis: an analysis of short-term (week 8-20) data from a real-world multicenter retrospective review	64
673 - Efficacy of nemolizumab in different subgroups of patients with prurigo nodularis in two randomized, placebo-controlled phase 3 trials	62
641 - Pooled efficacy, patient-reported outcomes, and safety of roflumilast cream 0.15% from the INTEGUMENT-1 and INTEGUMENT-2 phase 3 trials of adults and children with atopic dermatitis	61
603 - Ruxolitinib cream 1.5% twice daily for the treatment of extensive atopic dermatitis in children aged 2–11 years: 52 week results from a maximum-use trial	59
粒细胞集落刺激因子在化脓性汗腺炎中的作用	58
P51: Socioeconomic factors influence severity rather than incidence of dermatoses	57
PS04: Burden of treatment in adult patients with atopic dermatitis	57
P79: A review of proton pump inhibitor photosensitivity in a tertiary referral photodiagnostic centre	56
BH08: A rare and incidental finding of pili multigemini of the back	56
PA07: Scratching the surface: a review of online misinformation and conspiracy theories in paediatric atopic dermatitis	55
PD16: Behaviours, attitudes and the importance of sun safety via an Arduino development kit	54
一项在一家大型教学医院进行的 5 年皮肤附属器肿瘤研究, 对关联基因诊断提供了启示	51

对化疗所致脱发的更深入了解	51
The impact of Janus kinase 1 inhibitors on quality of life in patients with hidradenitis suppurativa	49
空气污染会导致皮肤颜色变深	49
BT06: Reporting time in two different teledermatology platforms	48
Understanding itch in epidermolysis bullosa (EB)	48
BG02: Muir‐Torre syndrome: a case of unusual coexisting genetic mutations	48
P15: Twenty years of the UK Dermatology Clinical Trials Network: past, present and future	46
Recognizing psoriasis in children and adolescents: the DIPSOC study	46
BH13: Scarring alopecia affecting a congenital melanocytic naevus in a patient with frontal fibrosing alopecia	46
P100: Efficacy of current treatments under study in patients with alopecia areata	46
How do dermatologists’ personal models inform a patient‐centred approach to management: a qualitative study using the example of prescribing a new treatment (Apremilast)*	46
CPC11: Bromoderma in a patient with chronic obstructive pulmonary disease	45
BH09: Frontal fibrosing alopecia in men: is it any different?	43
P57: New order: redesigning referral pathways to improve access for patients from dermatology outpatient waiting lists	43
H10: A Sweet diagnosis to make: the history of Robert Douglas Sweet and acute febrile neutrophilic dermatosis	43
开展健康宣传活动，禁售日光浴床，以减少皮肤癌: 合理利用医疗预算	43
P52: Opportunities for implementing a patient‐initiated follow‐up pathway in patients with psoriasis completing narrowband ultraviolet B phototherapy	42